Manasi P Jogalekar

Manasi P Jogalekar


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in Life
Verified
Journal Article
Open access
PDF file
VSVidya Sankarapandian
Vidya Sankarapandian
Balu Alagar Venmathi MaranBalu Alagar Venmathi Maran
Balu Alagar Venmathi Maran
Ramya Lakshmi RajendranRamya Lakshmi Rajendran
Ramya Lakshmi Rajendran
MJManasi P Jogalekar
Manasi P Jogalekar
SGSridharan Gurunagarajan
Sridharan Gurunagarajan
Byeong-Cheol AhnByeong-Cheol Ahn
Byeong-Cheol Ahn
Probiotics are living microbes that play a significant role in protecting the host in various ways. Gut microbiota is one of the key players in maintaining homeostasis. Cancer is considered one of the most significant causes of death worldwide. Although cancer treatment has received much attention in recent years, the number of people suffering from neoplastic syndrome continues to increase. Despite notable improvements in the field of cancer therapy, tackling cancer has been challenging due to the multiple properties of cancer cells and their ability to evade the immune system. Probiotics alter the immunological and cellular responses by enhancing the epithelial barrier and stimulating the production of anti-inflammatory, antioxidant, and anticarcinogenic compounds, thereby reducing cancer burden and growth. The present review focuses on the various mechanisms underlying the role of probiotics in the prevention and treatment of cancer.

9 March 2022 in Life
Verified
Journal Article
Open access
PDF file
LRLuciano C. Ramires
Luciano C. Ramires
Madhan JeyaramanMadhan Jeyaraman
Madhan Jeyaraman
Sathish MuthuSathish Muthu
Sathish Muthu
NANavaladi Shankar A
Navaladi Shankar A
Gabriel SantosGabriel Santos
Gabriel Santos
AEAlex Eickhoff
Alex Eickhoff
Orthobiologics are biological materials that are intended for the regeneration of bone, cartilage, and soft tissues. In this review, we discuss the application of orthobiologics in Achilles tendinopathy, more specifically. We explain the concepts and definitions of each orthobiologic and the literature regarding its use in tendon disorders. The biological potential of these materials can be harnessed and administered into injured tissues, particularly in areas where standard healing is disrupted, a typical feature of Achilles tendinopathy. These products contain a wide variety of cell populations, cytokines, and growth factors, which have been shown to modulate many other cells at local and distal sites in the body. Collectively, they can shift the state of escalated inflammation and degeneration to reestablish tissue homeostasis. The typical features of Achilles tendinopathy are failed healing responses, persistent inflammation, and predominant catabolic reactions. Therefore, the application of orthobiologic tools represents a viable solution, considering their demonstrated efficacy, safety, and relatively easy manipulation. Perhaps a synergistic approach regarding the combination of these orthobiologics may promote more significant clinical outcomes rather than individual application. Although numerous optimistic results have been registered in the literature, additional studies and clinical trials are still highly desired to further illuminate the clinical utility and efficacy of these therapeutic strategies in the management of tendinopathies.